<abstract xmlns="http://www.w3.org/1999/xhtml"><p> CKD is a problem of epidemic dimension. The risk of death and cardiovascular complications in this condition is of the same order of that by myocardial infarction, which qualifies CKD as “risk equivalent”. Calculations made on the basis of the epidemiological data of the MONICA-Augsburg study and analyses of the costs of myocardial infarction in a large health insurance company in Germany show that the economic burden of cardiovascular comorbidities with CKD in this country is substantial. These estimates, which may be valid also for other large member states of the European Community, represent a call for studies looking at the cost-effectiveness of preventive interventions aimed at reducing the risk for CKD and at lowering the concerning incidence rate of death and disability due to CKD-triggered cardiovascular complications in CKD patients.</p></abstract>

CKD is a problem of epidemic dimension. The risk of death and cardiovascular complications in this condition is of the same order of that by myocardial infarction, which qualifies CKD as “risk equivalent”. Calculations made on the basis of the epidemiological data of the MONICA-Augsburg study and analyses of the costs of myocardial infarction in a large health insurance company in Germany show that the economic burden of cardiovascular comorbidities with CKD in this country is substantial. These estimates, which may be valid also for other large member states of the European Community, represent a call for studies looking at the cost-effectiveness of preventive interventions aimed at reducing the risk for CKD and at lowering the concerning incidence rate of death and disability due to CKD-triggered cardiovascular complications in CKD patients.

Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD Patients

CNR-IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases, Ospedali Riuniti, 89124 Reggio Calabria, Italy

Epidemiology Department, High Institute of Public Health, Alexandria University, Alexandria. Egypt

Department of Nephrology Medical School, University of Ioannina Ioannina, Greece

Regione Calabria "Dipartimento Tutela della Salute e Politiche Sanitarie", Catanzaro, Italia

Nephrology, Hypertension and Renal Transplantation Unit, Ospedali Riuniti Reggio Calabria, Italy

PRILOZI

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

CKD is a problem of epidemic dimension. The risk of death and cardiovascular complications in this condition is of the same order of that by myocardial...

Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD Patients

Publicado en línea: 30 dic 2015

Páginas: 85 - 90

DOI: https://doi.org/10.1515/prilozi-2015-0056

Palabras clave
Chronic Kidney Disease (CKD), cardiovascular comorbidities, life-time risk

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD Patients

Publicado en línea: 30 dic 2015

Páginas: 85 - 90

DOI: https://doi.org/10.1515/prilozi-2015-0056

Palabras claveChronic Kidney Disease (CKD), cardiovascular comorbidities, life-time risk

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Palabras clave
Chronic Kidney Disease (CKD), cardiovascular comorbidities, life-time risk